Abstract Library

#3552 Fatigue and quality of life in patients with neuroendocrine neoplasia

Introduction: Neuroendocrine Neoplasms (NEN) are rare tumors and health related quality of life (HRQoL) may be modulated by the disease and the accompanying carcinoid syndrome seen especially in small intestinal NENs. Further, cancer related fatigue is one of the most common side effects of cancer and its treatments and may persist for years after treatment completion.

Conference:

Presenting Author: Hummelshøj N

Authors: Hummelshøj N, Grønbæk H, Bager P, Tabaksblat E, Dam G,

Keywords: Neuroendocrine, HRQoL, Fatigue, Patient reported outcome, Carcinoid syndrome,

#784 Incidence and Survival of Patients with Small Intestinal Neuroendocrine Tumors in a Danish NET Center

Introduction: Small intestinal neuroendocrine tumors (NET) have increased in incidence during the past decades. However, time trends from the Nordic countries are sparse.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Grønbæk H

Authors: Høj L, Nykjær K, Grønbæk H,

Keywords: neuroendocrine tumor, imaging, chromogranin A,

#783 A Comparison of Three Chromogranin A Assays in Patients with Neuroendocrine Tumors

Introduction: Chromogranin A (CgA) is the most important general tumor marker used in the diagnosis and follow-up of patients with neuroendocrine tumors (NET). CgA assays may have different sensitivities, which is of importance for the clinical diagnosis and handling of NET patients.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Grønbæk H

Authors: Høj L, Parkner T, Knudsen C, Grønbæk H,

Keywords: neuroendocrine tumor, Chromogranin A,

#487 Validation of Chromogranin A Assays in Patients with Neuroendocrine Tumors

Introduction: CgA is the most important biochemical marker for evaluation of NETs. Different assays with different accuracy exist.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Høj L, Parkner T, Knudsen C, Grønbæk H,

Keywords: neuroendocrine, CgA, assay,

#12 Chromogranin A as a predictor of progression, regression or stable disease in ileo-cecal (midgut) carcinoid tumors

Introduction: A general characteristic for NETs is their expression of certain proteins, such as chromogranin A (CgA), which is released from the dense core vesicles of NE cells, occasionally together with cell specific hormones, such as gastrin and serotonin. Plasma CgA seems to be closely related to tumor burden of intestinal carcinoid tumors in humans.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Mynster T, Jensen K, Hilsted L, Knigge U,

Keywords: chromogranin-A, carcinoid tumors, neuroendocrine tumors, computered tomography, ultrasonography, octreotide scintigraphy, somatostatin receptors, radioimmunoassay,